Loading...
XCNQVEXT
Market cap31mUSD
Dec 23, Last price  
0.19CAD
1D
0.00%
1Q
-26.00%
IPO
-87.24%
Name

Vext Science Inc

Chart & Performance

D1W1MN
XCNQ:VEXT chart
P/E
7.24
P/S
0.92
EPS
0.02
Div Yield, %
0.00%
Shrs. gr., 5y
54.56%
Rev. gr., 5y
13.51%
Revenues
35m
-1.69%
14,848,73018,476,26922,322,56825,193,95837,243,70935,410,63634,812,311
Net income
4m
-59.72%
4,107,2323,748,5622,793,3242,125,0684,986,71910,919,2804,398,447
CFO
4m
-25.29%
1,869,0362,409,636-393,3133,098,56211,681,3115,922,8254,424,704
Earnings
May 27, 2025

Profile

Vext Science, Inc., through its subsidiaries, operates as an integrated agricultural technology, services, and property management company in the cannabis industry in the United States. The company is involved in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, and edibles. It also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen and Pure Touch Botanicals brands. In addition, the company offers Vapen clear infused products, THC chocolate bars, THC syrup, THC snacks, candies, and gummies under Vapen Kitchens brand. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona .
IPO date
May 13, 2019
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
34,812
-1.69%
35,411
-4.92%
37,244
47.83%
Cost of revenue
36,614
22,135
24,479
Unusual Expense (Income)
NOPBT
(1,802)
13,276
12,764
NOPBT Margin
37.49%
34.27%
Operating Taxes
(1,036)
(4,221)
1,833
Tax Rate
14.36%
NOPAT
(766)
17,498
10,931
Net income
4,398
-59.72%
10,919
118.97%
4,987
134.66%
Dividends
Dividend yield
Proceeds from repurchase of equity
16,344
18,430
BB yield
-34.21%
-19.67%
Debt
Debt current
6,258
5,957
6,420
Long-term debt
35,094
33,090
7,949
Deferred revenue
31,459
7,432
Other long-term liabilities
(31,459)
(7,432)
Net debt
30,918
31,354
6,179
Cash flow
Cash from operating activities
4,425
5,923
11,681
CAPEX
(2,737)
(8,860)
(18,784)
Cash from investing activities
(4,824)
(30,313)
(27,098)
Cash from financing activities
3,186
23,857
20,138
FCF
(1,901)
2,447
(7,167)
Balance
Cash
8,720
5,934
6,467
Long term investments
1,714
1,759
1,723
Excess cash
8,694
5,922
6,327
Stockholders' equity
90,135
71,919
59,394
Invested Capital
124,885
100,687
67,167
ROIC
20.85%
19.39%
ROCE
12.07%
15.88%
EV
Common stock shares outstanding
164,735
139,535
146,414
Price
0.29
20.83%
0.24
-62.50%
0.64
-35.35%
Market cap
47,773
42.66%
33,488
-64.26%
93,705
1.20%
EV
78,691
64,842
99,884
EBITDA
7,791
19,711
16,053
EV/EBITDA
10.10
3.29
6.22
Interest
3,812
2,053
2,233
Interest/NOPBT
15.46%
17.49%